A major advance in the treatment of beta-thalassaemia and the official opening of the largest development project in the history of the Cyprus Institute of Neurology and Genetics (CING) mark a crucial week for medical research in Cyprus.
Researchers at CING on Friday unveiled a novel gene-editing strategy that could transform care for patients with beta-thalassaemia, a common inherited blood disorder in Cyprus, according to a study led by researcher
